Proof-of-concept trial of the combination of lactitol with Bifidobacterium bifidum and Lactobacillus acidophilus for the eradication of intestinal OXA-48-producing Enterobacteriaceae.
Juan Carlos Ramos-RamosFernando Lázaro-PeronaJosé Ramón ArribasJulio García-RodríguezJesús MingoranceGuillermo Ruiz-CarrascosoAlberto M BorobiaJosé Ramón Paño-PardoRafael HerruzoFrancisco ArnalichPublished in: Gut pathogens (2020)
The combination of prebiotics and probiotics was well tolerated. A rapid reduction on the OXA-PE intestinal loads was observed. At the EoT, decolonization was achieved in three patients.Clinical Trials Registration: NCT02307383. EudraCT Number: 2014-000449-65.
Keyphrases
- clinical trial
- klebsiella pneumoniae
- end stage renal disease
- acinetobacter baumannii
- ejection fraction
- chronic kidney disease
- newly diagnosed
- multidrug resistant
- pseudomonas aeruginosa
- phase ii
- prognostic factors
- phase iii
- study protocol
- drug resistant
- escherichia coli
- helicobacter pylori infection
- helicobacter pylori
- quantum dots
- double blind